Sign inJoin waitlistJoin the waitlist

Richard R. Furman

Director of the CLL Research Center · Weill Cornell Medicine

Credentials: · · · ·

History

CLL Research Center · Weill Cornell Medicine
Present
Weill Cornell Medicine
Present
Weill Cornell Medicine
Present

Mount Sinai School of Medicine
1993

Research

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia
New England Journal of Medicine · 2013 · 1,914 citations
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
New England Journal of Medicine · 2014 · Co-first of 27 authors · 1,384 citations
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia
New England Journal of Medicine · 2014 · 1,369 citations

John Leonard
54 papers
JB
John Byrd
43 papers
MC
Morton Coleman
43 papers
Peter Martin
36 papers
SO
Susan O'Brien
34 papers
Jennifer Brown
29 papers
Steven Coutre
29 papers
Jia Ruan
27 papers · 1 as a fellow
John Allan
27 papers
William Wierda
23 papers · 2 as a fellow
Jacqueline Barrientos
22 papers · 6 as a fellow
JS
Jeff Sharman
21 papers

Clinical trials

Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL
Principal investigator · Completed · Phase 2
Weill Medical College of Cornell University
2012–2020
Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL
Principal investigator · Completed · Phase 2
Weill Medical College of Cornell University
2007–2012
Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma
Principal investigator · Completed · Phase 1
Weill Medical College of Cornell University
2004